At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7 enrolled
Drug / intervention
Continuous Glucose Monitor (CGM)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Continuous Glucose Monitoring in Islet Transplant Recipients
In Brief
A clinical study evaluating Continuous Glucose Monitor (CGM) for Islet Transplantation and Type1 Diabetes Mellitus. Completed, enrolled 7 participants across 1 site.
Detailed Summary
A study assessing glucose variability in subjects with Type 1 Diabetes who have had islet transplant.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIslet Transplantation, Type1 Diabetes Mellitus
CountriesUnited States
CollaboratorsDexCom, Inc.
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedFeb 2018
Primary CompletionJul 2019
TodayJul 2026
First PostedFeb 9, 2018
Enrollment StartFeb 1, 2018
Primary CompletionJul 11, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.4 years ago
Interventions
Continuous Glucose Monitor (CGM)other
Study subjects will collect Continuous Glucose Monitor data for a minimum of 28 days but may continue for up to 3 months.